Literature DB >> 20347265

MicroRNAs and target site screening reveals a pre-microRNA-30e variant associated with schizophrenia.

Yong Xu1, Fei Li, Bo Zhang, Kerang Zhang, Fuquan Zhang, Xuezhu Huang, Ning Sun, Yan Ren, Manqiu Sui, Pozi Liu.   

Abstract

MicroRNAs (miRNAs) are short, non-coding RNAs that regulate the stability and translation of mRNA targets. Increasing evidence suggests that miRNAs could be involved in the initiation and progression of neuropsychiatric disorders. Prior to this study, six miRNAs had been reported to show a significantly abnormal expression level in schizophrenic brains. Also, common single nucleotide polymorphisms within two miRNA transcripts have shown genetic associations with schizophrenia. However, it remains largely unknown whether variants in these miRNA genes and/or in their target sites are associated with schizophrenia. Here, we selected the above eight miRNAs, plus 15 of their experimentally validated target sites, as candidate susceptibility factors for schizophrenia, for mutation screening and further association studies in Chinese case-control samples. We identified a new potentially functional variant ss178077483 located in the pre-mir-30e, which was strongly associated with schizophrenia (allelic P=0.00017; genotypic P=0.00015), with an odds ratio of 4.952 (95% confidence interval: 1.887-12.998). We also demonstrated that this new variant ss178077483, combined with mir-30e rs7556088 and mir-24-MAPK14 rs3804452, showed a weak gene-gene interaction for schizophrenia risk (P=0.001). In addition, analysis of gene expression demonstrated that expression of the mature mir-30e in the peripheral leukocytes was significantly higher in patients' group than in the control group (P=6.79e-7).This is the first study to indicate that mir-30e ss178077483 plays a role in schizophrenia susceptibility. It suggests that the contribution of mir-30e to the processes that lead to schizophrenia should be further investigated. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20347265     DOI: 10.1016/j.schres.2010.02.1070

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  39 in total

Review 1.  MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine-Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective.

Authors:  Andrea de Bartolomeis; Felice Iasevoli; Carmine Tomasetti; Elisabetta F Buonaguro
Journal:  Mol Neurobiol       Date:  2014-11-14       Impact factor: 5.590

Review 2.  Heterogeneity and individuality: microRNAs in mental disorders.

Authors:  Leif G Hommers; Katharina Domschke; Jürgen Deckert
Journal:  J Neural Transm (Vienna)       Date:  2014-11-14       Impact factor: 3.575

3.  Constructing and characterizing a bioactive small molecule and microRNA association network for Alzheimer's disease.

Authors:  Fanlin Meng; Enyu Dai; Xuexin Yu; Yan Zhang; Xiaowen Chen; Xinyi Liu; Shuyuan Wang; Lihua Wang; Wei Jiang
Journal:  J R Soc Interface       Date:  2013-12-18       Impact factor: 4.118

4.  Expression quantitative trait loci (eQTLs) in microRNA genes are enriched for schizophrenia and bipolar disorder association signals.

Authors:  V S Williamson; M Mamdani; G O McMichael; A H Kim; D Lee; S Bacanu; V I Vladimirov
Journal:  Psychol Med       Date:  2015-03-30       Impact factor: 7.723

Review 5.  MicroRNAs in neuronal function and dysfunction.

Authors:  Heh-In Im; Paul J Kenny
Journal:  Trends Neurosci       Date:  2012-03-19       Impact factor: 13.837

Review 6.  Dysregulation of miRNA and its potential therapeutic application in schizophrenia.

Authors:  Ting Cao; Xue-Chu Zhen
Journal:  CNS Neurosci Ther       Date:  2018-03-12       Impact factor: 5.243

7.  Association Between hsa-miR-30e Polymorphisms and Sporadic Primary Hyperparathyroidism Risk.

Authors:  Maria Mizamtsidi; Konstantinos Nastos; Fausto Palazzo; Vasilis Constantinides; Roberto Dina; Megan Farenden; George Mastorakos; Ioannis Vassiliou; Maria Gazouli
Journal:  In Vivo       Date:  2019 Jul-Aug       Impact factor: 2.155

8.  Gender-specific reduction of estrogen-sensitive small RNA, miR-30b, in subjects with schizophrenia.

Authors:  Nikolaos Mellios; Marzena Galdzicka; Edward Ginns; Stephen P Baker; Evgeny Rogaev; Jun Xu; Schahram Akbarian
Journal:  Schizophr Bull       Date:  2010-08-23       Impact factor: 9.306

9.  Association between two single nucleotide polymorphisms at corresponding microRNA and schizophrenia in a Chinese population.

Authors:  Mengna Zou; Dongdong Li; Ruixue Lv; Yi Zhou; Tingting Wang; Jinnan Liu; Chuanmin Tao; Binwu Ying; Lanlan Wang
Journal:  Mol Biol Rep       Date:  2011-06-29       Impact factor: 2.316

Review 10.  miRNAs in NMDA receptor-dependent synaptic plasticity and psychiatric disorders.

Authors:  Hongmei Shen; Zheng Li
Journal:  Clin Sci (Lond)       Date:  2016-07-01       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.